Andrea Tesvich Murina, MD, FAAD
SESSIONS
F030 How to Approach Challenges in Hidradenitis Suppurativa Management: Strategies to Optimize Use of HS Therapies
Mar 8, 2025
•
9:00 AM - 12:00 AM
•
Valencia Ballroom A
U045 Combining Systemic Therapies: Should You Do It?
Mar 8, 2025
•
4:30 PM - 12:00 AM
•
Valencia Ballroom A
HANDOUTS
Login to view handouts
DISCLOSURES
AbbVie – Advisory Board(Honoraria), Speaker(Honoraria); Amgen – Speaker(Honoraria); Botanix Pharmaceuticals – Speaker(Honoraria); Galderma – Speaker(Honoraria); Janssen Biotech – Speaker(Honoraria); Leo Pharma – Advisory Board(Honoraria); Novartis – Speaker/Faculty Education(Honoraria); Ortho Dermatologics – Speaker(Honoraria); Pfizer Inc. – Speaker(Honoraria); UCB Pharma – Speaker(Honoraria); VeraDermics Inc. – Advisory Board(Honoraria);